Evidence map›Paper›PMID 14738452›Full record

ArticleClinical and experimental immunology2004

Detection of HLA class II-dependent T helper antigen using antigen phage display.

R Somasundaram, K Satyamoorthy, L Caputo, H Yssel, D Herlyn

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

R SomasundaramThe Wistar Institute, Philadelphia, PA 19104, USA.
K Satyamoorthy
L Caputo
H Yssel
D Herlyn
The Wistar Institute · USHôpital Arnaud de Villeneuve · FR

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
TUMOR DEVELOPMENT AND PROGRESSION IN HUMAN MELANOCYTESP01CA025874 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 1985 to 2015
$19.0M
MONOCLONAL ANTIIDIOTYPE AGAINST COLORECTAL CANCERR01CA060975 · NCI · WISTAR INSTITUTE · PI HERLYN, DOROTHEE M · 1994 to 1997
–
NCI NIH HHS CA10815NCI NIH HHS CA25874-22NCI NIH HHS CA60975NCI NIH HHS CA88193NCI NIH HHS P01 CA025874NCI NIH HHS P30 CA010815
6 · The paper itself

Abstract

Major histocompatibility complex (MHC) class II-dependent antigens not only activate CD4+ T helper (Th) cells, but also cytolytic T lymphocytes and effector cells of the innate immune system. These antigens therefore are candidate vaccines against cancer and infectious agents. We have developed a novel approach using a model antigen, tetanus toxoid (TT), which provides the basis for the establishment of a novel strategy of cloning Th antigens. In the TT model system, a cDNA library encoding part of the TT light chain which contained a TT-associated Th epitope recognized by TT-specific Th clones was displayed on a phage vector (TT-phage) and presented to TT-specific Th cells by autologous Epstein-Barr virus-transformed B cells (APC). These TT-phages were able to specifically activate two different TT-specific CD4+ Th cell lines as demonstrated both in [3H]thymidine incorporation and cytokine release assays. Th cell stimulation by TT-phages was significant at a ratio of one TT-phage in 50 irrelevant phages. The described approach provides the basis for the development of a novel strategy of cloning MHC class II-dependent Th antigens, using available Th cells. This strategy has several potential advantages over existing antigen cloning methods or biochemical peptide isolation.

Indexed as

Antigen PresentationBacteriophagesB-LymphocytesCD4 AntigensCD4-Positive T-LymphocytesCell Line, TransformedCloning, MolecularCytokinesDNA, ViralEnzyme-Linked Immunosorbent AssayEpitopesGenetic VectorsHerpesvirus 4, HumanHistocompatibility Antigens Class IIHumansTetanus ToxoidCD4 AntigensCytokinesDNA, ViralEpitopesHistocompatibility Antigens Class IITetanus ToxoidThymidineViral Proteins

Identifiers

PMID14738452
PMCPMC1808955
OpenAlexW2035506997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.